pertechnetate
Small moleculeexperimentalImaging agent
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Oct 15, 2020 (NCT04724538)
Timeline
2020s
- Jan 1, 2020
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
- Mol. weight
- 163 g/mol
- Chirality
- Achiral Molecule
- Inorganic
- Yes
- Polymer
- No
- Imaging
- 99-technetium
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109884 ↗
Also known as
- pertechnetate
- pertechnetate
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04724538 | Phase 1/Phase 2 (Phase 2) | Oct 15, 2020 | Government of Russia |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Russia | Government | 1 | 1 | 1 | 2020 |
1 organizations
Page 1 / 1